- Report
- August 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,566GBP
€3838EUR$4,150USD£3,208GBP
- Report
- August 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,566GBP
€3838EUR$4,150USD£3,208GBP
- Report
- July 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,566GBP
€3838EUR$4,150USD£3,208GBP
- Report
- July 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,566GBP
€3838EUR$4,150USD£3,208GBP
- Report
- July 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,566GBP
€3838EUR$4,150USD£3,208GBP
- Report
- July 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,566GBP
€3838EUR$4,150USD£3,208GBP
- Report
- February 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,566GBP
€3838EUR$4,150USD£3,208GBP
- Report
- January 2026
- 160 Pages
Global
From €2923EUR$3,160USD£2,443GBP
€3653EUR$3,950USD£3,053GBP
- Report
- January 2026
- 160 Pages
Global
From €2923EUR$3,160USD£2,443GBP
€3653EUR$3,950USD£3,053GBP
- Report
- November 2025
- 160 Pages
Global
From €2923EUR$3,160USD£2,443GBP
€3653EUR$3,950USD£3,053GBP
- Report
- November 2025
- 160 Pages
Global
From €2923EUR$3,160USD£2,443GBP
€3653EUR$3,950USD£3,053GBP
- Report
- July 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,566GBP
€3838EUR$4,150USD£3,208GBP
- Report
- August 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,566GBP
€3838EUR$4,150USD£3,208GBP
- Report
- August 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,566GBP
€3838EUR$4,150USD£3,208GBP
- Report
- August 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,566GBP
€3838EUR$4,150USD£3,208GBP
- Report
- July 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,566GBP
€3838EUR$4,150USD£3,208GBP
- Report
- July 2026
- 130 Pages
Global
From €4486EUR$4,850USD£3,749GBP
- Report
- February 2026
- 89 Pages
Global
From €3500EUR$4,054USD£3,028GBP
- Report
- February 2026
- 170 Pages
Global
From €4486EUR$4,850USD£3,749GBP
- Report
- September 2026
- 52 Pages
Global
From €6937EUR$7,500USD£5,798GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more